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Abstract
Background: Non-small cell lung cancer is the most common type of lung cancer. Surgery is proven to be the
most effective treatment in early stages, despite its potential impact on quality of life. Pulmonary rehabilitation,
either before or after surgery, is associated with reduced morbidity related symptoms and improved exercise
capacity, lung function and quality of life.
Methods: We describe the study protocol for the open-label randomized controlled trial we are conducting on patients
affected by primary lung cancer (stages I-II) eligible for surgical treatment. The control group receives standard care
consisting in one educational session before surgery and early inpatient postoperative physiotherapy. The treatment
group receives, in addition to standard care, intensive rehabilitation involving 14 preoperative sessions (6 outpatient and 8
home-based) and 39 postoperative sessions (15 outpatient and 24 home-based) with aerobic, resistance and respiratory
training, as well as scar massage and group bodyweight exercise training.
Assessments are performed at baseline, the day before surgery and one month and six months after surgery. The main
outcome is the long-term exercise capacity measured with the Six-Minute Walk Test; short-term exercise capacity, lung
function, postoperative morbidity, length of hospital stay, quality of life (Short Form 12), mood disturbances (Hospital
Anxiety and Depression Scale) and pain (Numeric Rating Scale) are also recorded and analysed. Patient compliance and
treatment-related side effects are also collected. Statistical analyses will be performed according to the intention-to-treat
approach. T-test for independent samples will be used for continuous variables after assessment of normality of
distribution. Chi-square test will be used for categorical variables. Expecting a 10% dropout rate, assuming α of 5% and
power of 80%, we planned to enrol 140 patients to demonstrate a statistically significant difference of 25 m at Six-Minute
Walk Test.
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Discussion: Pulmonary Resection and Intensive Rehabilitation study (PuReAIR) will contribute significantly in investigating
the effects of perioperative rehabilitation on exercise capacity, symptoms, lung function and long-term outcomes in
surgically treated lung cancer patients. This study protocol will facilitate interpretation of future results and wide
application of evidence-based practice.
Trial registration: ClinicalTrials.gov Registry n. NCT02405273 [31.03.2015].
Keywords: Rehabilitation, Lung neoplasms, Exercise therapy, Patient education, Breathing exercises, Exercise tolerance,
Quality of life, Patient compliance
Background
Lung cancer accounts for a fifth of the total global bur-
den of disability-adjusted life years due to cancer [1].
Non-small cell lung cancer (NSCLC) is the most preva-
lent type of all lung cancers [1], with surgical resection
appearing to be the most effective treatment in early
stages (Stages I and II) [2].
Although surgical resection results in higher survival
rates [3], it is associated with significant morbidity, func-
tional limitations and decreased quality of life (QoL) [4].
Long-term physical impairment is an important and un-
desirable consequence of surgery, limiting patients’ recov-
ery to a greater extent than do other severe pulmonary
complications, such as atelectasis, dyspnoea and pneumo-
nia [2, 5]. Furthermore, chronic obstructive pulmonary
disease (COPD) is frequent in lung cancer patients and is
associated with increased postoperative morbidity and
mortality [6–8].
Recent studies suggest that perioperative pulmonary
rehabilitation (PR) programmes including exercise may
improve exercise capacity, functional performance and
QoL, both pre- and postoperatively [2, 9].
PR is a comprehensive intervention that includes exer-
cise training (endurance and resistance), education and
behaviour changes [10, 11]. PR is also part of the new in-
tegrated pathways for enhanced recovery, where it has
shown to improve patient satisfaction and to reduce in-
hospital stay [12].
Surgical candidates seem to benefit from preoperative
PR. In COPD patients, preoperative PR is correlated
with improvement in functional parameters, which in
turn may increase resection rate and allow more exten-
sive lung resections [3, 10].
It is well known that exercise training is associated
with significant increase in peak oxygen consumption
(VO2peak) [13–15], which has been confirmed as a
strong independent predictor of perioperative or postoper-
ative complications and overall long-term survival for in-
dividuals with NSCLC [11, 16]. Indeed, patients with
reduced exercise tolerance and low VO2peak show poorer
thoracic surgical outcomes [11, 16]. Therefore, preopera-
tive PR could reduce symptoms and morbidity, shorten
hospital stay and lower healthcare costs [17, 18].
Concerning postoperative PR, recent literature sup-
ports improvement in exercise capacity through physical
training [5, 19], whereas there is not sufficient evidence
supporting meaningful clinical changes in lung function
[5, 9, 19, 20]. The effectiveness of postoperative PR on
QoL is still controversial, although some studies suggest
that exercise training could be advantageous for some
domains of QoL [19, 20].
Both pre- and postoperative PR tailored to lung cancer
patients has been demonstrated to be safe and feasible
[21, 22], although research conducted in this field pre-
sents dissimilarities concerning type of intervention, in-
tensity, setting and timing [2, 5].
An updated, extensive literature review on periopera-
tive physical exercise interventions was conducted by
our group to establish the most updated and evidence-
based interventions for patients undergoing surgery for
NSCLC [23]. Based on its results, the best available evi-
dence supports the inclusion of high intensity aerobic
training for upper and lower limbs (primarily cycling
and/or walking) and respiratory exercise (primarily in-
spiratory muscle training) in the perioperative period.
Postoperative programmes should also include strength
training and balance training. Therapeutic interventions
can be conducted in both outpatient and home-based
settings. Although this review focused on the exercise
components of rehabilitation, most treatment protocols
also include routine physiotherapy with dyspnoea man-
agement and airway clearance techniques. With regards
to the length of interventions, while the duration of the
preoperative phase is strictly determined by the time of
elective surgery, postoperative intervention ranges from
6 to 20 weeks.
In summary, systematic reviews conducted in this
field advocate the value of both pre- and postoperative
PR programmes, with aerobic training as the most
relevant component. However, this literature demon-
strates that primary research validity has been limited
by poor methodological quality and small and hetero-
geneous samples of clinical studies [2, 5, 23]. Thus,
there is the need to build stronger evidence regarding
the effectiveness of evidence-based PR interventions in
this population.
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Rationale
The literature review provided sufficient evidence to jus-
tify a clinical trial to investigate the effects of pre- and
postoperative intensive rehabilitation in patients affected
by NSCLC undergoing surgical resection. Pulmonary Re-
section and Intensive Rehabilitation (PuReAIR) random-
ized controlled trial is designed to assess the effect of
intensive PR on improving exercise capacity measured
with the Six-Minute Walk Test (6MWT) in such patients.
The effects of intensive PR on postoperative morbidity,
length of hospital stay (LoS), QoL, pain, depression and
lung function will also be recorded.
The study protocol provides a detailed description of
the interventions to accurately interpret results, which
will be published on completion.
Study objectives
Primary aim
The primary aim of this study is to investigate the effect-
iveness of intensive PR on exercise capacity in surgically
treated NSCLC patients six months after surgery.
1.2.1.1.Primary outcome measure The primary out-
come measure to assess the superiority of intensive PR
over standard care (SC) is the change in distance walked
in six minutes (6MWD) measured six months after sur-
gery, compared to baseline.
Secondary aims
The secondary aims of this study are to investigate the
effectiveness of intensive PR on:
1. Short-term exercise capacity
2. Lung function
3. Postoperative complications
4. Length of hospital stay
5. Quality of life
6. Mood disturbances
7. Pain
Secondary outcome measures
The secondary outcomes are:
1. Change in 6MWD measured one month after
surgery and compared to baseline
2. Forced expiratory volume in 1 s (FEV1), forced vital
capacity (FVC) and diffusing lung capacity for
carbon monoxide (DLCO) measured six months
after surgery and compared to baseline
3. Postoperative complications registered one month
and six months after surgery as specific events
4. Interval (in days) between the date of the operation
and the date of discharge
5. Change in Short Form 12 questionnaire (SF-12)
scores measured six months after surgery and
compared to baseline
6. Change in Hospital Anxiety and Depression Scale
(HADS) score measured the day before surgery and
six months after surgery, compared to baseline
7. Change in Numeric Rating Scale (NRS) score
measured one month and six months after surgery,
compared to baseline.
Additional assessments
Data regarding patient compliance and treatment-related
side effects during both preoperative and postoperative
intensive PR will also be collected.
Intensive PR includes the implementation of hospital-
based and home-based training. Patients randomized to
the treatment group are requested to register the activ-
ities performed at home on a training log; distance in
kilometres, number of steps and heart rate achieved dur-
ing aerobic walking and exercises performed during re-
spiratory muscle training (RMT) session are recorded.
As patient adherence to protocol is a crucial issue in re-
habilitation and the literature recommends the consist-
ent and explicit reporting of exercise attendance in
people with respiratory diseases [24], the proportion of
training sessions performed are collected to assess pa-
tient compliance: adherence to the protocol is defined as
the achievement of 80% or more of the training exercises
prescribed [25].
We consider as minor side effects self-reported pain
or discomfort in the muscles/joints involved with the
physical component of the treatment; major side effects
include any trauma secondary to a fall requiring specific
interventions or symptomatic alterations of the basic
vital signs (i.e., blood pressure, heart rate) arising during
or shortly after the end of exercise and confirmed by in-
strumental measurement.
To evaluate the actual effect of lung resection on the
study population before the postoperative treatment,
FEV1, FVC and DLCO are also registered in the experi-
mental group one month after surgery and compared to
baseline.
Methods
Study design
A single institution 1:1 randomized controlled open-label
trial with two parallel arms, powered for superiority, has
been designed in accordance with the CONSORT state-
ment and Helsinki declaration. The study has been ap-
proved by the local Ethical committee [n. 2013/0009390]
and funded by the Italian Ministry of Health [GR-2011-
02351711].
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Participants and setting
All patients with highly suspicious or diagnosed primary
NSCLC are screened for eligibility criteria within the Lung
Cancer Multi-Disciplinary Team Meeting at Arcispedale
Santa Maria Nuova (ASMN) of Reggio Emilia, Italy. This
is an Institute for Advanced Technologies and Healthcare
Protocols in Oncological Research certified by the
Organization of European Cancer Institutes in 2014. The
Thoracic Surgery Unit’s catchment area covers a range of
about 535,000 inhabitants and performs an average of 500
operations per year, including about 130 lung resections
for malignancies.
Patients with Stages I and II NSCLC are considered
for enrolment if they qualify for surgery. We exclude
candidates who require adjuvant therapies and patients
unfit for the physical exercise required by intervention
[Table 1]. In patients affected by COPD, medical treat-
ment is reviewed and optimized according to the most
recent Global Initiative for Chronic Obstructive Lung
Disease guidelines at the start of the selection process,
to minimize confounding factors.
Written informed consent is obtained from partici-
pants by the operating surgeon during the preoperative
consultation. Subsequently, patients undergo baseline as-
sessment and afterwards are randomized to receive in-
tensive PR (Intervention Group - IG) or SC (Control
Group - CG) (Fig. 1).
Measurements
Patients included in the study are assessed at baseline
(T0), the day before surgery (T1), one month after sur-
gery (T2) and six months after surgery (T3) [Table 2].
Baseline assessments are carried out immediately be-
fore randomization (T0) and include lung function, exer-
cise capacity, QoL, mood disturbances and pain.
Static and dynamic respiratory volumes and DLCO are
measured with full pulmonary function tests (PFTs). Exer-
cise capacity is evaluated with 6MWT, according to
current guidelines [11, 26]. Data on QoL are assessed with
SF-12 [27], mood disturbances are evaluated using the
HADS [28] and pain is quantified using the NRS [29].
The day before surgery (T1), all patients are re-
assessed for mood disturbances. PFTs are repeated in
the IG; treatment-related side effects and patient adher-
ence to the intensive preoperative PR are also recorded.
One month after surgery (T2), patients repeat exercise
capacity and pain evaluation using the same tools
employed at baseline (T0). Data regarding LoS, postopera-
tive complications and 30-day mortality are also recorded
at this stage. Postoperative complication categories in-
clude acute respiratory failure, cardiac failure (including
myocardial infarction), surgical site infection (including
pneumonia and bronco-pleural fistula), arrhythmias
(including atrial fibrillation), thrombosis and pulmonary
embolism, neurological impairment (including stroke) and
other (specified).
Long-term follow-up takes place 6 months after sur-
gery (T3) and includes the assessment of lung function,
exercise capacity, QoL, mood disturbances, pain and late
postoperative complications. In the IG, patient adher-
ence to the intensive postoperative PR and side effects
are also recorded at 6 months.
To tailor the intensity of training, at T0 and T2
(immediately before initiation of pre- and postoperative PR)
patients in IG perform:
- Shuttle walking test, to determine initial intensity of
aerobic training [30];
- 10 repetition maximum test, to determine initial load
of resistance training [31].
Treatment protocols
Patients randomized to CG are provided with the SC
already in place in our hospital. Patients randomized to
IG follow an evidence-based intensive PR programme
developed by the research group and delivered in
addition to SC.
Control group
Patients allocated to CG receive SC, which consists of
one therapeutic education session delivered by physician
and physiotherapist the day before surgery and early in-
patient postoperative PR, delivered by physiotherapist.
The therapeutic educational session lasts 30 to 40 min
and involves counselling and self-care management. The
aim of counselling is to prepare the patients for the post-
operative course, emphasising breathing exercise and
sputum clearance techniques, pain control strategies and
Table 1 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Patients affected by NSCLC in Stage I-II Tumour stage requiring adjuvant therapies
Patients eligible for lung resection Patients unfit for the type of physical exercise
included in study protocol
Patients able to walk autonomously
without medical devices (e.g., crutches)
Patients affected by sensorial or cognitive
deficits with potential severe impact on
compliance (deafness, blindness, dementia, etc.)
Patients able to give informed consent
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self-care. More specifically, breathing exercises focus on
diaphragmatic breathing to prevent or relieve discomfort
(shortness of breath, anxiety, pain), deep breathing to
better ventilate all lung lobes and clearance techniques
(huffing). These techniques are explained and repeatedly
performed until the patient has mastered them. Self-care
management involves pain relief and postural advice, as
well as mobility techniques and practical advice in order
to better cope with post discharge issues which could
arise at home.
From day 1 after surgery until discharge patients receive
daily early inpatient postoperative PR, which includes
breathing exercises and positive expiratory pressure
training with PEP bottle (PEP training) for a duration
Fig. 1 Study Flow diagram. Legend: MDT = Multi-Disciplinary Team; PR = pulmonary rehabilitation; Preop = preoperative; Postop = postoperative
Table 2 Assessments
T0
Baseline
Randomization T1
1 day before surgery
(14÷21 days from baseline)
T2
(1 month ± 5 days
after surgery)
T3
(6 months ± 5 days
after surgery)
IG CG IG CG IG CG
Pulmonary function (PFTs) x x x x
Exercise capacity (6MWT) x x x x x
Quality of life (SF-12) x x x
Mood disturbances (HADS) x Randomization x x x x
Pain (NRS) x x x x x
Length of stay x x
Postoperative complications x x x x
IG Intervention Group, CG Control Group, PFTs Pulmonary Function Tests, 6MWT Six-Minute Walk Test, SF-12 Short form 12, HADS Hospital Anxiety and Depression
Scale, NRS Numeric Rating Scale
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of 30 to 40 min every day. Upon discharge, patients
are advised to continue breathing exercises and main-
tain an active lifestyle.
Intervention group
Patients allocated to the IG receive SC plus intensive
PR, which includes a total of 53 sessions (14 preopera-
tive and 39 postoperative).
2.4.2.1.Preoperative intensive PR Preoperative inten-
sive PR is organised into six outpatient sessions per-
formed two to three times per week, plus eight home-
based sessions performed three to four times per week.
The overall duration of this treatment ranges from 14 to
21 days, starting the same day the patient is listed for
surgery or immediately afterwards, to minimize the delay
in offering surgical treatment and to avoid the 30-day
breach, as recommended by the regional guidelines [32].
Each outpatient session lasts approximately two hours
and consists of an individual, supervised and persona-
lised combination of the following elements:
 Therapeutic education, whose contents are the same
as those provided to CG. It is delivered during the
first outpatient session and repeated, if necessary,
during the course of the treatment.
 Aerobic training, which consists of 30 to 40 min on
a cycle ergometer. This training is maintained at the
intensity of 60–80% peak workload (previously
determined with shuttle walking test) [30] and
includes a 5-min warm up and a 5-min cool down.
Within this range, the intensity of training is
adapted to the patient’s tolerance.
 Resistance training for lower limbs (extensor muscle
group), upper limbs (biceps, triceps, deltoids,
latissimus dorsi, pectoralis) and abdominal wall. Each
exercise is performed for two to three sessions of 10
repetitions at the maximal load (previously determined
with the 10-repetition maximum test) [31];
 RMT which includes breathing pattern training, PEP
training and inspiratory muscle training for at least
15 to 30 min. Inspiratory muscle training is
performed by means of a pressure threshold device,
with a load ≥30% of maximal predicted inspiratory
pressure; intensity is adapted to the patient’s
tolerance.
Each home-based session lasts approximately one hour
and consists of an individual, unsupervised and persona-
lised combination of RMT, performed twice a day, plus
30 min of aerobic walking at the intensity of 60–80% of
maximal heart rate. Patients are given a portable pedom-
eter and a heart rate monitor and are requested to rec-
ord their adherence to home-based training in the
training log, which collects kilometres, steps and heart
rate achieved during aerobic walking and exercises per-
formed during RMT session.
2.4.2.2.Postoperative intensive PR Postoperative PR
starts one month after surgery and includes 39 sessions
divided into 15 outpatient sessions performed twice a
week and 24 home-based sessions performed three times
per week. Overall, the postoperative PR programme lasts
8 weeks.
Each outpatient session takes approximately two hours
and 15 min and includes both aerobic and resistance
training, following the same procedures described for
preoperative PR, plus RMT for the first eight sessions.
In addition, outpatient postoperative PR includes
10 min of scar massage during the first four weeks and
group bodyweight exercise training, scheduled once a
week for the entire duration of the programme.
Each home-based session lasts approximately one hour
and consists of an individual, unsupervised and perso-
nalised combination of RMT performed twice a day
and 30 min of aerobic walking at the intensity of 60–
80% of maximal heart rate, monitored by patients with
the portable device provided. Once again, patients are
requested to record their adherence to home-based
training by the training log.
At the end of postoperative PR, patients are advised to
continue aerobic training and RMT until the 6-month
follow-up is completed (T3).
Standardization of procedures
All other aspects of patient management, such as peri-
operative care, general anaesthetic, intraoperative airway
management and ventilation settings, postoperative anal-
gesia, perioperative care and discharge plans, are rou-
tinely performed according to the current institutional
protocols.
In particular, analgesia is provided and reviewed by the
anaesthesiologist team and involves the positioning of epi-
dural catheter before induction. Naropine 500 mg + Mor-
phine 20 mg are administered though epidural catheter
for the first 48 h, starting at the end of surgical procedure,
with paracetamol 1 g every eight hours and ketoprofen
1 fl intravenously. Epidural catheter is removed usually on
the third day after drainage elimination and therapy is
shifted per os until discharge. Pain killer reduction is
started one week after discharge.
To ensure the highest level of standardization of both
the administration of treatments and the evaluations,
two physiotherapists have been specifically trained for
the purpose of this study; they are also responsible for
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collecting data regarding the outcome measurements
(i.e., 6MWT, SF-12, HADS, NRS).
Withdrawal from trial
Participation in the study will be withdrawn if any of the
following occurs:
a) Patient referred for adjuvant treatment
b) Patient lost to follow-up
c) Patient withdrawal of consent
d) Death of the patient
All withdrawals are recorded specifying the reason.
Statistical considerations
Sample size
Since data for mean and standard deviations of 6MWT
after lung surgery with or without treatment have never
been published, Cohen’s medium effect size (d = 0.5) has
been used to compute sample size based on the minimal
significant variation reported (25 m) [33].
We also expect a potential dropout rate of about 10%
for the aforementioned reasons. Thus, assuming 5% type
I error and 80% power for this study, we plan to enrol
140 patients (about 70 patients in each arm).
Randomization procedure
Patient enrolment is performed by the study data man-
agers or physicians with a phone call to the local Re-
search and Statistics Unit, which generated the
allocation sequence: the responder simultaneously enters
the patient and caller names and uses a predefined
randomization list to make the assignment. Group allo-
cation is revealed to researchers performing interven-
tions and to patients after baseline evaluations (T0) are
completed.
Blinding
This is an open-label study, due to the limited number
of professionals involved in a single institution project.
Statistical analysis
Statistical analyses will be performed according to the
intention-to-treat approach. Statistical techniques per
study aims are as follows:
 Primary aim: t-test for independent samples to com-
pare the mean of the change (defined as T3 – T0 re-
lated date) in 6MWD between IG and CG. In case
of heteroscedasticity, checked by folded F test, the
Satterthwaite adjustment will be used.
 Secondary aims:
- t-test for independent samples to compare the
mean of the change between IG and CG for
6MWD (T2 – T0 change), FEV1, FVC, DLCO and
SF-12 score (T3 – T0 change), HADS score (T1 -
T0 and T3 - T0), NRS score (T2 – T0 and T3 –
T0) and LoS. In case of heteroscedasticity, checked
by folded F test, the Satterthwaite adjustment will
be used.
- chi-square test to compare the proportion of
postoperative complications between IG and CG;
Five percent significance will be used to assess the p-
values and 95% two-sided confidence interval will be
provided for each tested parameter; the confidence inter-
vals will be calculated assuming normal distribution.
Statistical calculations will be performed by the local
Research and Statistics Unit using SAS System release
9.2 or later, R release 3.3.3 or later, SPSS release 23 or
later, according to the availability at the time of the data
analysis.
Patient adherence to protocol may be a crucial issue in
determining the efficacy of rehabilitation programmes,
including exercise training. Although it has not been
plainly demonstrated, in principle, non-attendance could
affect exercise dose and influence the outcome of treat-
ment [34]. Therefore, if patient compliance, is less than
80% [25], we will proceed with a second per-protocol
analysis.
Duration and timeline
The study started enrolling in 2015. Results are expected
by the end of 2017.
Discussion
The main aim of PuReAIR is to assess the effective-
ness of intensive combined pre- and postoperative PR
in improving exercise capacity, lung function and
long-term outcomes (QoL, pain, anxiety and depres-
sion) in lung cancer patients surgically treated with
curative intent.
So far, the long-term effect of physical therapy on ex-
ercise tolerance and quality of life has only been re-
ported in small series, and recent reviews have
highlighted the need for well-designed studies to collect
stronger evidence and clarify the role of perioperative
PR [2, 5, 23].
The RCT design adopted allows reducing possible
sources of bias (selection bias) and confounding factors
which could be embedded in the heterogeneity of the
target population. Moreover, this study design was pow-
ered according to an a priori specified hypothesis of su-
periority of intensive PR compared to SC.
The intervention of any trial should always be based
on the best available evidence and described in sufficient
detail to be reproducible. The study protocol provides a
detailed description of the interventions delivered; this is
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particularly important in trials focusing on complex in-
terventions, as is the case in rehabilitation. In fact, a
comprehensive description of both standard care and
additional treatments allows an accurate interpretation
of the conclusions and ensures the correct replication of
the protocol described, if appropriate, in order to com-
pare results.
The definition of the best PR treatment programme
required a careful review of the current literature [23],
resulting in the definition of the following key elements:
 The inclusion of both aerobic and strength training
of lower and upper limb muscles [2, 11, 35];
 The combination of outpatient and home-based
treatment sessions. This should facilitate the enrol-
ment of patients referred from provincial hospitals
and might increase their compliance, minimizing the
risk of attrition bias;
 The inclusion of inspiratory muscle training,
incentive spirometry, airway clearance techniques
and/or respiratory exercises, as lung cancer leads to
respiratory impairment and COPD is a frequent
comorbidity in patients affected by lung cancer [19,
20, 36, 37];
 The inclusion of group exercise training sessions
during the postoperative phase, alongside individual
guided and monitored home-based training, to facili-
tate mutual support among patients with NSCLC,
whose vulnerable psychosocial condition could affect
postoperative functioning and QoL [38]. In fact, a
recent systematic review examining the spectrum of
health care needs among people with lung cancer
showed that psychological, emotional and social
needs were most frequently specified and lack of ac-
knowledgement of patients’ status by others were
perceived as important issues [39]. Therefore, group
sessions may facilitate the sharing of feelings, experi-
ences and concerns, and may support patients in
coping with their illness;
 The inclusion of scar massage in the
postoperative phase to relieve tissue tension and
reduce pain. In our clinical experience, patients
frequently report pain and hypersensitivity around
surgical scar.
At the time of planning this protocol, we estimated
an overall 10% withdrawal rate, mainly due to peri-
operative morbidity and mortality, as well as unfore-
seen N1/N2 lymph nodal involvement diagnosed after
surgery and requiring adjuvant therapies. However,
more recent literature suggests a greater incidence of
intraoperative lymph nodal upstaging [40] and even
when an accurate staging workup is performed, in-
cluding PET/CT and EBUS-TBNA when appropriate,
minimal involvement of hilar nodes (N1 stage) re-
mains difficult to assess preoperatively. Furthermore,
more aggressive protocols are recommended by inter-
national guidelines in treating N1 NSCLC [41]. A
greater than expected number of patients may there-
fore withdraw post randomization to ensure they re-
ceive the best cancer care.
In addition, because preoperative diagnosis may not al-
ways be obtained and, whenever possible, it seems to be
a significant barrier to trial enrolment [42], we chose to
include patients without proven cancer histology, pro-
viding that the clinical evaluation is consistent with ma-
lignancy (PET positivity, history of smoking, radiological
features of malignancy, absence of concomitant extra-
thoracic malignancies).
The exclusion of patients undergoing adjuvant therap-
ies might represent a limit of this study, because it leads
to a further selection of patients that could impact re-
producibility in the future. However, in patients with
lung cancer little is known about feasibility of physical
exercise during chemo or radiotherapy, whose side ef-
fects might offset the potential benefits of PR. Thus, we
chose to sacrifice broader inclusion criteria to find reli-
able answers, first and foremost, in the population that
could most benefit from PR.
We emphasize the need for a timely delivery of pre-
operative PR to comply with the regional guidelines,
which recommend starting cancer treatments within
30 days from referral [32]. If the results of this study
show a clear benefit of intensive PR in patients with lung
cancer, especially in improving QoL, a future trial on
combined PR and non-radical treatments to extend the
benefit of improved functioning to patients with ad-
vanced disease may be warranted. Likewise, the use of
preoperative PR, if beneficial, will need to be evaluated
in patients with severe COPD to increase the rate of
lung resection.
Conclusion
Due to the growing interest in perioperative PR, we are
confident that PuReAIR will contribute significantly to
providing reliable recommendations for systematic appli-
cation of PR to patients undergoing surgery for early
stage lung cancer. Moreover, the hybrid intervention
adopted (inpatient-outpatient and home-based, group
and individual sessions) could facilitate adherence to the
protocol, which is determined by a combination of per-
sonal and health-related factors and might be pivotal in
the rehabilitation of individuals with NSCLC [43]. The
results of PuReAIR will be disseminated and will help
healthcare professionals in implementing effective and
affordable strategies to improve the care of cancer
patients.
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